A Naturalistic Study of Ketamine for Treatment Resistant Mood Disorders
This study is completed. It focuses on depression and currently lists study information in Poland.
In Gdansk
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed. It focuses on depression and currently lists study information in Poland.
In GdanskThis study is active but not recruiting. It focuses on anxiety and currently lists study information in Norway.
Multiple locations, including BodøThis study is completed. It focuses on anxiety and currently lists study information in the United States.
In ManhattanThis study is completed. It focuses on schizophrenia and currently lists study information in the United States.
In La JollaThis study is active but not recruiting in the United States. It is testing Open-label Placebo for Depression.
In San FranciscoThis study is completed. It focuses on depression and currently lists study information in the United States.
In DallasThis study has public registry information. It focuses on bipolarity and currently lists study information in the United States.
In VenturaThis study has public registry information. It focuses on OCD and currently lists study information in the United States.
In VenturaThis study is completed in Global. It focuses on Schizophrenia.
In GlobalThis study is completed. It focuses on ADHD and currently lists study information in the United States.
In WayneThis study is completed. It focuses on PTSD and currently lists study information in the United States.
In TucsonThis study is completed. It focuses on ADHD and currently lists study information in the United States.
In WilmingtonHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.